Monday, 28 January 2019

Research Report and Overview on Surgical Sealants and Adhesives Market, 2018

Market Scenario:

Global surgical sealants and adhesives market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 2.12 billion in 2017 and is projected to grow at a CAGR of 9.3% over the forecast period.

The factors such as growing prevalence and incidence of various disorders, growth in the number of accidents, and growth in the number of surgeries are expected to propel the growth of the market. According to the Centers for Disease Control and Prevention (CDC), in 2015, about 2.8 million people were hospitalized due to injuries. However, lack of reimbursements policy; and extensive clinical data requirements for launching products hamper the market growth over the forecast period.
Key players
  1. Bard, Inc. (US), Johnson & Johnson (UK), Baxter International, Inc. (US), Medtronic plc (US), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (US), Sanofi Group (France), Sealantis, Ltd (Israel), Vivostat A/S (Denmark), and Ocular Therapuetix, Inc. (US) are some of the key players in the global surgical sealants and adhesives market.
Segmentation
The global surgical sealants and adhesives market has been segmented into product, indication, application, and end user.
Based on product, has been segmented into natural/biological sealants and adhesives and synthetic and semisynthetic sealants and adhesives. The natural/biological sealants and adhesives and synthetic segment is accounted for the largest share segment of the market in 2017.
The market, by indication, has been segmented into surgical hemostasis, tissue sealing, and tissue engineering.
The market, by application, has been segmented into general surgeries, cardiovascular surgeries, central nervous system surgeries, orthopedic surgeries, urological surgeries, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical sealants and adhesives market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European surgical sealants and adhesives market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The surgical sealants and adhesives market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Surgical Sealants and Adhesives market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global surgical sealants and adhesives market owing to a well-developed healthcare sector, increasing surgeries, technological advancement, and rising geriatric population.
Europe is expected to hold the second largest position in the global surgical sealants and adhesives market. The market growth in this region is attributed to the increasing surgical procedures and developed healthcare infrastructure.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
The surgical sealants and adhesives market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the huge patient population of chronic diseases in the countries such as India and China.


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Friday, 25 January 2019

Endovascular Aneurysm Repair Devices Market Volume Forecast and Value Chain Analysis 2018

Market Scenario
Global endovascular aneurysm repair devices market is likely to grow significantly over the forecast period. It is estimated that the global endovascular aneurysm repair devices market is expected to record a CAGR ~ 6.4 % during the forecast period of 2018 to 2023. The weakening and bulging of the aorta is called aortic aneurysm. The bulging can cause a leak that spills blood into the body. It can direct the blood flow away from the organs and tissues, causing severe complications, such as kidney damage, heart attacks, stroke, and even death. Thus, endovascular repair can be done by placing a stent-graft in an aneurysm through a small hole in the blood vessels in the groin area.
Numerous factors such as reduced recovery times, low-cost hospitalization charges, and technological advancements in repair devices are expected to drive the growth of the market. For instance, in March 2017, Terumo Corporation completed the acquisition of Bolton Medical, Inc. with the acquired company being a leading innovator in thoracic and abdominal stent graft systems, Terumo Corporation aimed to strengthen its growth in vascular graft segment.
However, stringent government regulation, the preferable alternative of open surgery and various complications such as endoleaks and infections may hamper the market growth during the assessment period.
Key players
  • Cardiatis SA,
  • Cardinal Health,
  • Cook Medical LLC,
  • Endologix, INC.,
  • Jotec GmbH,
  • Medtronic plc,
  • Terumo Corporation,
  • L. Gore & Associates, Inc.,
  • BiFlow Medical Ltd,
  • Boston Scientific Corporation,
  • Braile Biomédica,
  • Endoluminal Sciences Pty Ltd,
  • Endospan Ltd.,
  • Getinge AB,
  • Lemaitre Vascular Inc.
Segmentation
The global endovascular aneurysm repair devices market has been segmented into indication, site, anatomy, and products.
The market, on the basis of indication, has been segmented into the abdominal aortic aneurysm, thoracic aortic aneurysm and others.
The market, based on thoracic aortic aneurysm, has been further segmented into ascending aortic aneurysm, descending aortic aneurysm, thoracoabdominal aortic aneurysm, and thoracic arch aortic aneurysm.
The market, on the basis of the site, has been segmented into infrarenal and pararenal.
The market, based on pararenal site, has been sub-segmented into juxtarenal and suprarenal.
The market, on the basis of anatomy, has been segmented into traditional and complex.
The market, on the basis of products, has been segmented into percutaneous EVAR, fenestrated EVAR, aortic stents and TAA grafts, and others.
Regional Market Summary
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The endovascular aneurysm repair devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The Americas is expected to dominate the global endovascular aneurysm repair devices market owing to increasing geriatric population, and well-developed healthcare sector. With the increase in the geriatric population, the prevalence of aneurysms is also expected to rise. The Centers for Disease Control and Prevention (CDC) ranks abdominal aortic aneurysm as one of the top 15 causes of mortality in the United States, but only for those between 85 and 89 years. According to the Centers for Disease Control and Prevention, aortic aneurysms were the primary cause of 9,863 deaths in 2014 in the US.
Europe is expected to hold the second largest position in the global endovascular aneurysm repair devices market. The market growth in this region is attributed to the growing prevalence of aneurysms, availability of funds for research, and favorable reimbursement scenario.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to the growing government initiatives for the healthcare sector.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population and continuously developing economies.
Browse Complete 100 Pages Premium Research Report Enabled with 110 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485

Surgical Drills Market Dynamics, Forecast, Analysis and Supply Demand 2018

Market Scenario:
Global Surgical Drills Market is expected to grow significantly over the forecast period. The market held a market value of USD 463.64 million in 2017 and is projected to grow at a CAGR of 4.93% over the forecast period.
Surgical drills as the name itself suggests, are drill machines which are used during the various surgical procedures. Their main function is to drill, cut, and bore holes in the bone in order to attach surgical pins, plates, or screws. There are several types of surgical drills available which are powered by different source. These include pneumatic drills, electric drills, and battery powered drills among others. Surgical drills have simplified the tedious job of a surgeon and reduced the surgery time significantly. Surgical drills have become an important tool in the surgical procedures. Increasing number of orthopedic and dental surgeries, high awareness about the dental hygiene and high disposable income are some of the factors contribute to the growth of the surgical drills market.
Key players:Adeor medical AG, AlloTech Co.Ltd. Arthrex Inc., B.Braun Melsungen AG, CONMED Corporation, De Soutter Medical, DePuy Synthes, Medtronic plc, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key players in the global surgical drills market.
Segmentation:The Global Surgical Drills Market has been segmented into product, application and end-user.Based on products, the market has been segmented into, pneumatic drills, electric drills, battery powered drills, accessories, and others. The pneumatic drills segment is expected to account for the largest share in the global surgical drills market in 2017. This large share is majorly attributed to the wider acceptance of the devices, and better patient compliance as compared to other products. Based on application, the market has been segmented into orthopedic surgery, neurosurgery, ENT, dental surgery, and other. The orthopedic surgery segment is expected to account for the largest share in the global surgical drills market in 2017 followed by dental surgery segment.Based on end-users, the market has been segmented into hospitals & clinics, ambulatory surgical centers, academic and research institutes, and others. The hospitals & clinics segment is expected to account for the largest share in the global surgical drills market in 2017. At the same time, the increasing establishments of the ambulatory surgical centers in the developed and developing countries has led this segment to grow at the fastest rate during the forecast period.
Based on the regions, the market for surgical drills is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical drills market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.European surgical drills market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The surgical drills market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical drills market in the Middle East & Africa has been segmented into regions such as the Middle East and Africa.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global surgical drills market owing to the rising number of the orthopaedic surgeries, increasing awareness about dental hygiene leading to increase in dental procedures and surgeries. The development of the better surgical approaches and advanced treatment procedures have affected the growth of the American market in a positive way. Moreover, high awareness among American population, state of the art medical infrastructure, high disposable income, are some of the many factors that drive the growth of the surgical drills market in this region.
Europe is expected to hold the second largest market share in the global surgical drills market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the surgical drills market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East & Africa region is anticipated to show minor growth opportunities in the surgical drills market during the forecast period.

Neuroendoscopy Market Growth and Restrain Factors Analysis By 2023

Market Scenario:
Neuroendoscopy is characterized as a minimally-invasive surgical procedure which is extensively utilized to remove tumors. The excision occurs via small holes present in the skull, i.e., through the mouth or nose. In neuroendoscopy procedures, a small telescopic device equipped with a high-resolution video camera and an eyepiece is used. This gives the neurosurgeons, an ability to navigate and effectively access the parts of the brain that could not be addressed by traditional surgery. Some of the other advantages of neuroendoscopy include fast recovery, minimal scarring, and others. The increasing prevalence of brain tumors is a major driver for the market growth. According to a study published by the Neuro-Oncology Journal in 2015, the global incidence rate for all types of brain tumors was estimated to be about 10.82 per 100 000 persons.
Moreover, the increasing demand for minimally invasive surgical procedures, growing geriatric population, and favorable reimbursement policies are estimated to boost the market during the forecast period. According to the National Institute of Health in 2016, the global geriatric population is estimated to be more than triple from 2015 to 2050, i.e., it is projected to grow from 126.5 in 2015 million and reach 446.6 million by 2050. However, a shortage of physicians and high cost for neuroendoscopy procedures and equipment are projected to restrain the market growth during the forecast period. The Association of American Medical Colleges in 2016 stated that the demand for physicians continued to grow at a higher rate, exceeding the supply. The projected total physician shortfall by 2025 is estimated to be in between 61,700 and 94,700.
Global Neuroendoscopy Market is expected to grow at an approximate CAGR of 5.2% during the forecast period.
Key players
The key players in the global neuroendoscopy market are KARL STORZ (Germany), B. Braun (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hangzhou Hawk Optical Electronic Instruments (China), Machida Endoscope (Japan), Tonglu Wanhe Medical Instrument (China), Schindler Endoskopie (Germany), Clarus Medical (U.S.), LocaMed (U.K), Visionsense Corporation (U.S.), Olympus Corporation (Japan), Zeiss International (Germany), Stryker (U.S.), Medtronic (U.S.), and others.
Segmentation
The global Neuroendoscopy market is segmented on the basis of product, application, usability, and end-user.
On the basis of products, the market is segmented into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment is sub-segmented into rigid video scopes and rigid fiberscopes. On the basis of application, the market is categorized into transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuro-endoscopy. On the basis of usability, the market is segmented into reusable neuroendoscopes and disposable neuroendoscopes. On the basis of end-users, the market is segmented into hospitals, clinics, medical research centers, and others.
Regional Analysis
The Americas dominates the global neuroendoscopy market. Factors such as the increasing prevalence of brain tumors, the presence of a well-developed healthcare sector, and huge health care expenditures within the region drive the market growth within the region. Moreover, the presence of key players such as Stryker and Medtronic, besides others and the growing geriatric population within the region fuel the market growth.
Europe stands second in the global neuroendoscopy market due to the increasing demand for minimally invasive surgeries, rising availability of funds for research and development, and a huge patient population. According to the Cancer Research U.K., the total number of new cases for brain tumor was estimated to be about 11,432 in 2015.  
Followed by Europe, Asia Pacific stands third in the global neuroendoscopy market. Moreover, the region is projected to be the fastest growing region in the global market. This can be attributed to the presence of developing economies such as China, growing patient population, developing healthcare sector, and increasing per capita healthcare expenditures. Additionally, favorable government policies support the market growth. Medical tourism and rising geriatric population are estimated to fuel the market growth. According to the Indian Brand Equity Foundation, the medical tourism industry in India is estimated to grow rapidly and reach USD 9 billion by 2020.
The Middle East and Africa holds the least share in the global neuroendoscopy market due to the presence of poor economies, stringent government policies, lack of awareness, low per capita income, and poor availability of healthcare services, especially within the African region. A majority of the neuroendoscopy market within the region is held by the Middle East due to the presence of a well-developed healthcare sector and huge healthcare expenditure.
Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/neuroendoscopy-market-5836

Digital Wound Measurement Devices Market, Trends, Absolute Opportunity and Value Chain 2018

Market Scenario
The Global Digital Wound Measurement Devices Market is expected to witness a positive growth during the forecast period. Digital wound measurement devices enable monitoring of chronic wounds and deliver the appropriate drug dose to speed up the process of healing. Chronic wounds if not treated on time can lead to severe infections and amputations. Hence, digital wound measurement devices allow delivering tailored treatments after the 2D or 3D assessment of the infection and inflammation. The increasing number of patients suffering from chronic wounds drives the market growth. According to the Intermountain Healthcare (2017), 6.5 million people in the US suffer from chronic wounds. Diabetic wounds are severe, and the process of healing is very long and eventually may lead to amputations. Hence factors such as growing diabetic patients, rising geriatric population, and an increasing number of surgeries are major factors influencing the growth of the market. The emergence of smartphones, rapid use of advanced digital tools, and the advent of telehealth for wound care will also contribute for the market to grow.

However, factors such as, the inability of the device to provide additional information about wounds such as moistness or exudation and high costs of digital devices are expected to restrict the market growth during the forecast period.
Key Players
  • WoundRight Technologies Tissue Analytics
  • Parable Health
  • ARANZ Medical Limited
  • eKare, Inc,
  • KCI,
  • an Acelity Company,
  • WoundMatrix, Inc.,
  • WoundZoom Inc.,
  • Kent Imaging Inc.,
  • WoundRight Technologies, LLC,
  • WoundVision, LLC,
  • Hitachi Healthcare Americas,
  • Smith & Nephew plc.

Segmentation
The global digital wound measurement devices market is segmented on the basis of wound type, product, and end-user. The digital wound measurement devices market, by wound type is sub-segmented into a diabetic ulcer, chronic wounds, burns, incisional, and traumatic. The product segment is sub-segmented into contact wound measuring devices and non-contact wound measuring devices.
On the basis of end-user, the market is segmented into hospitals, clinics, and ambulatory surgical centers.
Regional Market
The digital wound measurement devices market is dominated by North America owing to the rising prevalence of chronic wounds and technological advancements in the healthcare sector.  In June 2018, KCI, an Acelity Company announced the launch of Nurse2Nurse (N2N) Mobile App for wound care nurses. The app allows interactions with clinicians and shares credible insights and information for better patient care.
It is estimated that Europe was the second largest in the global digital wound measurement devices market. The increasing technological advancement and research for wound care along with government support in Europe drive the market growth in this region. The European Wound Management Association will conduct its 29th conference by June 2019 in Gothenburg, Sweden in the presence of several international wound management communities with the common goal of improving the care of wound patients.
Asia-Pacific was projected to be the fastest growing region for the global digital wound measurement devices market. Key factors such as rising geriatric population, growing diabetic patient pool, high incidence chronic wounds, and developing healthcare infrastructure drive the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world diabetic population is in Asia. This provides favorable backgrounds for the market to grow in Asia.
The Middle East and Africa holds the least share of the global digital wound measurement devices market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investments by private market players in this region can boost the market growth. 

Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/digital-wound-measurement-devices-market-6289

Nasal Drug Delivery Market Trends and Drivers Analysis 2018 To 2023

Market Scenario
The nasal route administration is experiencing tremendous growth due to its noninvasive nature consequently reducing pain and threat of infections. It allows the patient to self-administer drugs thus not requiring any external help. The high vasculature, high permeability, and low enzymatic environment of nasal cavity are perfectly apt for systemic delivery of drug molecules via nose. There is no risk of drug destruction by hydrogen chloride (HCl) present in the stomach thereby increasing bioavailability which reduces the dosage of the drug. This, in turn, leads to proportional reduction in side effects.
Increasing popularity of over-the-counter nasal drugs such as inhalers for the common cold is also propel the market in an upward manner. Nasal drugs prove to be advantageous for the market, with a plethora of factors like good penetration of the drugs into the nasal cavity, improving patient compliance, rapid absorption, onset of action, and requirement of low dosage.
Key Players
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi-Aventis
  • Merck & Co., Inc.
  • AptarGroup Inc.
  • Johnson & Johnson Services, Inc.
  • GlaxoSmithKline plc
  • Becton Dickson & Company

Drivers and Restraints
The market for nasal drug delivery is growing remarkably with a consistently good CAGR due to the benefits accompanying nasal drugs.  Other driving factors include innovation of drugs which are absorbed easily from the nasal route, innovations in advanced products which allow the delivery of precise doses and also ease of administration. However, the restraints that threaten the growth of the market are irritation of the nasal route and the low dose of the drug that can be delivered as compared to other routes of administration. Other constraints include concurrent low popularity of the route which reduces economies of scale in producing these delivery devices and low awareness. According to an extensive report by Market Research Future (MRFR), the Middle East and Africa nasal drug delivery market is presumed to reach around USD 1.59 billion in 2022 surging at a CAGR of 8.1% from 2017 to 2022. The market was estimated to be worth USD 1 billion in 2015.
Regional Analysis
UAE is the largest market for nasal drug delivery in entire Middle East and Africa nasal drug delivery Market closely followed by Egypt. The rest of Africa’s market is growing at a very fast rate due to huge unmet medical needs and growing popularity of nasal route.
Segmentation
Middle East and Africa nasal drug delivery market has been segmented on the basis of dosage form which comprises of drops, sprays, powder, gels and ointments. On the basis of system, market is segmented into unit dose, multi-dose and metered dose. On the basis of delivery technologies; market is segmented into spray, nebulizers and other. On the basis of therapeutic applications; market is segmented into rhinitis, congestion, vaccinations and others.
Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/nasal-drug-delivery-market-2696

Wednesday, 23 January 2019

India CRO Market Segmentation Detailed Study with Forecast Up To 2018

Market Synopsis of India CRO Market:
A Contract Research Organization (CRO) offers outsourced services to support R&D functions for pharmaceutical, biotechnology, and health companies. The services may be clinical research, product development such as drug development or process development such as bio analytical assay development. A CRO may also provide management services such as clinical trials management, and pharmacovigilance.
The India CRO market restraints are rising concern for security especially data security and patient security in clinical trials, lack of collaboration between universities and industry. Further, the compromises done by some India CROs on ethical and technical standards are the major market threat.
The India CRO Market growth is expected to flourish at a CAGR of 12.0% during the forecast period.
India has rapidly become one of the preferred destinations for clinical trials owing to its large heterogeneous patient pool, rapidly transforming healthcare market, highly educated physicians and cost competitiveness propels the market growth. In addition, increased investment from foreign companies as well as local market players either individually or in collaboration is likely to boost the market growth during the forecast period. Further, emerging research areas such as diagnostic research are expected to fuel the India CRO market.
Key Players for India CRO Market: 
  • Quintiles IMS Holdings, Inc.
  • Pharmaceutical Product Development
  • Siro Clinpharm
  • GVK Bio
  • Clininvent
  • CliniRX Tangent Research
  • Ecron Acunova
  • Ace Biomed Pvt. Ltd.
  • Actimus Biosciences Pvt. Ltd.
  • Alkem Laboratories Ltd.
  • Actis Biologics Pvt Ltd.
Segments:
India CRO market has been segmented on the basis of service types which comprises clinical trials, product development, process development, post-marketing surveillance, quality monitoring and others. On the basis of therapeutic application; market is segmented into oncology, cardiovascular, neurology, nephrology and urology, and others. On the basis of end users; market is segmented into pharmaceutical/biopharmaceutical companies, medical devices companies and academic institutes.
Regional Analysis of India CRO Market:
The healthcare sector of India is divided between differential geographic regions and states. The South India and western India account for a major share of the Indian CRO market. However of late the CRO industry is shifting to the North. The reasons for this shift is the concentration of regulatory authority such as Director Controller General of India (DCGI) office, Indian Council of Medical Research (ICMR), Directorate General of Foreign Trade (DGFT), Department of Biotechnology (DBT) etc. Also the costs are lower in North India and the genetic pool is more diverse.
Browse Complete 70 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/india-cro-market-2927 

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com